Apple has recently been developing noninvasive sensors for monitoring blood sugar levels in order to cater to the needs of diabetes patients. A whole new species of wearable healthcare devices such as Apple watch and its ilk are on the rise. According to unnamed sources, feasibility trials are in progress at its clinical sites in Bay Area.
Emergence of Cutting-edge Medical Devices to Ramp up Apple’s Portfolio
This development is not surprising, considering the tech giant’s recent moves. In 2016, two new Apple health apps, 3D4 Medical and AirStrip made their appearance. With the introduction of CareKit, ResearchKit, and HealthKit, the evolution of medical devices for diabetes is only an evident advancement in the company’s trajectory.
The acquisition of Gliimpse, a personal health record startup in August 2016 was a strategic groundwork for extending Apple’s presence in the healthcare vertical. Founded in Silicon Valley in 2013, Gliimpse aims to offer ‘personalized and shareable medical records’ to every single patient across the U.S.
IBM Watson Health and Microsoft Emerge as Key Contenders
However, Apple is not the singular entity to plunge into the promising healthcare terrain. In January 2017, IBM Watson Health announced its distinct collaboration with Best Doctors, a leading clinical consultation provider, with the common objective of offering key insights on the available options in the treatment of cancer. On receiving patients’ approval, the Best Doctors team can collect medical records and then feed the necessary data into Watson. Watson will in turn generate a report that will be assessed by the globally renowned oncologists in the network of Best Doctors.
Microsoft has also been targeting healthcare domain by joining hands with two different entities, Twist Biosciences and the University of Pittsburgh Medical Center.